VF
TVTX icon

Virtu Financial’s Travere Therapeutics TVTX Stock Holding History

Virtu Financial’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$652K Buy
+11,470
New +$509K 0.02% 446
2024
Q4 		– Sell
-21,500
Closed -$301K – 2069
2024
Q3 		$301K Buy
+21,500
New +$224K 0.02% 628
2024
Q1 		– Sell
-19,498
Closed -$175K – 2116
2023
Q4 		$175K Buy
+19,498
New +$142K 0.01% 881

Other funds holding TVTX

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Virtu Financial's TVTX Position: Q2 2026 in Review

Virtu Financial opened a new position in Travere Therapeutics (TVTX) in Q2 2026: 11,470 shares worth $652K. The stake represents 0.02% of the portfolio and ranks #446 among its holdings. This is a return to the name: Virtu Financial previously reported a position in TVTX as recently as Q3 2024.

Virtu Financial first reported a position in TVTX in Q4 2023 and has held it in 3 quarters since. 321 funds tracked by Wall St. Rank hold TVTX as of Q2 2026.

  • Virtu Financial held 11,470 shares of Travere Therapeutics worth $652K as of Q2 2026.
  • Travere Therapeutics was a new Virtu Financial position in Q2 2026.
  • Travere Therapeutics made up 0.02% of Virtu Financial's portfolio in Q2 2026, its #446 holding.
  • Virtu Financial first reported a position in Travere Therapeutics in Q4 2023 and has held it in 3 quarters since.
  • 321 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.